Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-11 Sale | 2025-06-13 4:31 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 400,000 | $11.4 | $4,560,360 | 12,278,992 (Direct) | View |
| 2025-06-11 Sale | 2025-06-13 4:30 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 400,000 | $11.4 | $4,560,520 | 13,190,168 (Direct) | View |
| 2025-05-27 Sale | 2025-05-29 4:16 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 400,000 | $9.3349 | $3,733,944 | 12,678,992 (Direct) | View |
| 2025-05-27 Sale | 2025-05-29 4:15 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 400,000 | $9.3364 | $3,734,579 | 13,590,168 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 4:06 pm | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $9.3933 | $1,502,928 | 74,824 (Direct) | View |
| 2025-04-29 Sale(A) | 2025-05-22 4:05 pm | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $8.9208 | $1,427,328 | 234,824 (Direct) | View |
| 2025-05-15 Sale | 2025-05-16 4:31 pm | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $8.57 | $685,600 | 2,679,999 (Direct) | View |
| 2025-05-14 Sale | 2025-05-16 4:30 pm | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 40,000 | $8.44 | $337,600 | 241,880 (Direct) | View |
| 2025-05-06 Sale | 2025-05-08 4:30 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 114,984 | $8.8216 | $1,014,343 | 2,546,472 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:32 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 49,200 | $8.9502 | $440,350 | 2,911,456 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:31 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 587,008 | $9.0484 | $5,311,479 | 14,078,992 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:30 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 587,008 | $9.0481 | $5,311,279 | 14,990,168 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:59 pm | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 26,072 | $8.98 | $234,127 | 780,169 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:58 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 90,360 | $8.98 | $811,433 | 16,697,664 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:56 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 34,384 | $8.98 | $308,768 | 3,380,832 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:55 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 90,360 | $8.98 | $811,433 | 15,786,488 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:53 pm | Verona Pharma plc | VRNA | Sinha Vikas Director | 20,000 | $8.9208 | $178,416 | 350,440 (Direct) | View |
| 2025-03-12 Sale | 2025-03-13 8:15 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 79,264 | $8.3511 | $661,942 | 2,608,976 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 5:51 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 870,672 | $5.0062 | $4,358,787 | 14,204,752 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 5:50 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 881,960 | $5.0064 | $4,415,452 | 13,293,736 (Direct) | View |
| 2024-11-27 Sale | 2024-12-02 7:20 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 113,240 | $5.0055 | $566,822 | 14,175,696 (Direct) | View |
| 2024-11-27 Sale | 2024-12-02 7:19 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 125,328 | $5.0047 | $627,233 | 15,075,424 (Direct) | View |
| 2024-11-25 Sale | 2024-11-26 6:36 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 2,400 | $5 | $12,000 | 14,288,936 (Direct) | View |
| 2024-11-25 Sale | 2024-11-26 6:35 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 1,600 | $5 | $8,000 | 15,200,752 (Direct) | View |
| 2024-11-25 Sale | 2024-11-26 6:34 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 240,000 | $4.9015 | $1,176,360 | 2,671,480 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-20 Exercise | 2025-05-22 4:06 pm | N/A 2032-04-27 | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $0 | 74,824 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 4:06 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $0.5038 | 74,824 (Direct) | View |
| 2025-04-29 Exercise(A) | 2025-05-22 4:05 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 120,384 | $1.7 | 234,824 (Direct) | View |
| 2025-04-29 Exercise(A) | 2025-05-22 4:05 pm | N/A 2027-04-26 | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $0 | 234,824 (Direct) | View |
| 2025-04-29 Exercise(A) | 2025-05-22 4:05 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 39,616 | $0.5038 | 234,824 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-16 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $2.113 | 2,679,999 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-16 4:31 pm | N/A 2034-03-31 | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $0 | 2,679,999 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 40,000 | $1.9338 | 241,880 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 4:30 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 40,000 | $0 | 241,880 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:32 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 50,000 | $0 | 2,911,456 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 200,000 | $0 | 14,078,992 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 140,000 | $1.9338 | 1,476,003 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:30 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 140,000 | $0 | 1,476,003 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 200,000 | $0 | 14,990,168 (Direct) | View |
| 2025-03-19 Gift | 2025-05-01 8:59 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 1 | $0 | 780,169 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:59 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 86,064 | $0 | 780,169 (Direct) | View |
| 2025-04-29 Option Award | 2025-05-01 8:59 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 253,120 | $0 | 780,169 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:58 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 229,512 | $0 | 16,697,664 (Direct) | View |
| 2024-08-07 Option Award | 2025-05-01 8:58 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 1,875,000 | $0 | 16,697,664 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:56 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 86,064 | $0 | 3,380,832 (Direct) | View |
| 2024-08-07 Option Award | 2025-05-01 8:56 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 553,120 | $0 | 3,380,832 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:55 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 229,512 | $0 | 15,786,488 (Direct) | View |
| 2024-08-07 Option Award | 2025-05-01 8:55 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 1,875,000 | $0 | 15,786,488 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:53 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 15,048 | $1.7 | 350,440 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:53 pm | N/A 2027-04-26 | Verona Pharma plc | VRNA | Sinha Vikas Director | 20,000 | $0 | 350,440 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:53 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 4,952 | $0.5038 | 350,440 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:24 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:18 pm | N/A N/A | Verona Pharma plc | VRNA | Ullman Anders Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:17 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:16 pm | N/A N/A | Verona Pharma plc | VRNA | SHAH MAHENDRA Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:15 pm | N/A N/A | Verona Pharma plc | VRNA | Edwards Martin Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:12 pm | N/A N/A | Verona Pharma plc | VRNA | Deschamps Lisa Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:11 pm | N/A N/A | Verona Pharma plc | VRNA | Cunningham Kenneth Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:09 pm | N/A N/A | Verona Pharma plc | VRNA | Austwick Michael Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:09 pm | N/A N/A | Verona Pharma plc | VRNA | Brady James Aloysius Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 5:08 pm | N/A N/A | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 100,000 | $1.9338 | 1,476,003 (Direct) | View |
| 2025-02-26 Gift | 2025-02-28 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 64,000 | $0 | 1,476,003 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 64,000 | $0.775 | 1,476,003 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 96,000 | $2.67 | 1,476,003 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 4:30 pm | N/A 2031-08-08 | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 460,000 | $0 | 1,476,003 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 200,000 | $0.5038 | 1,476,003 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-04 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 200,000 | $0 | 14,238,024 (Direct) | View |
| 2025-02-03 Tax Withholding | 2025-02-04 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 166,728 | $7.1625 | 14,238,024 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-04 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 200,000 | $0 | 13,326,848 (Direct) | View |
| 2025-02-03 Tax Withholding | 2025-02-04 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 166,888 | $7.1625 | 13,326,848 (Direct) | View |
| 2025-02-01 Option Award | 2025-02-04 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 50,000 | $0 | 2,688,240 (Direct) | View |
| 2025-02-03 Tax Withholding | 2025-02-04 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 33,240 | $7.1625 | 2,688,240 (Direct) | View |